Walleye Capital LLC grew its position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 32.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 251,220 shares of the medical device company’s stock after buying an additional 61,526 shares during the quarter. Walleye Capital LLC’s holdings in Globus Medical were worth $12,473,000 as […]
Primecap Management Co. CA bought a new stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 52,425 shares of the medical device company’s stock, valued at approximately $2,603,000. Several other large investors have also recently bought and sold shares of GMED. Nicholas Company […]
Globus Medical (NYSE:GMED – Free Report) had its target price lifted by Truist Financial from $58.00 to $60.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a hold rating on the medical device company’s stock. Several other brokerages also recently weighed in on GMED. Royal Bank of Canada reaffirmed an […]
Globus Medical (NYSE:GMED – Get Free Report) had its price objective increased by stock analysts at Truist Financial from $58.00 to $60.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the medical device company’s stock. Truist Financial’s target price would suggest a potential upside of 8.58% […]
Globus Medical (NYSE:GMED – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.68 to $2.70 for the period, compared to the consensus earnings per share estimate of $2.69. The company issued revenue guidance of $2.450 billion to $2.475 billion, compared to the consensus revenue estimate […]